AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16186399 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.25 mg/day ramipril
Number of subjects: 34
Study 16186399 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/day ramipril
Number of subjects: 34
Study 16186399 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 12017397 — intervention group
Group type: EXPERIMENTAL
Intervention: Almotriptan 6.25 mg
Number of subjects: 1777
Study 12017397 — intervention group
Group type: EXPERIMENTAL
Intervention: Almotriptan 12.5 mg
Number of subjects: 1777
Study 12017397 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1777
Study 12017397 — intervention group
Group type: COMPARATOR
Intervention: Sumatriptan 100 mg
Number of subjects: 1777
Study 9890408 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg/day for first 4 weeks, then 10 mg/day for second 4 weeks)
Number of subjects: 250
Study 9890408 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study 9890408 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 250
Study 7742162 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxacin with water
Number of subjects: 8
Study 7742162 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxacin with milk
Number of subjects: 8
Study 7742162 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxacin with a standard breakfast
Number of subjects: 8
Study 7742162 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxacin with a breakfast and milk
Number of subjects: 8
Study 2048675 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 15 micrograms/kg
Number of subjects: 36
Study 2048675 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 35 micrograms/kg
Number of subjects: 36
Study 2048675 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 55 micrograms/kg
Number of subjects: 36
Study 2048675 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 75 micrograms/kg
Number of subjects: 36
Study 2048675 — intervention group
Group type: COMPARATOR
Intervention: Atracurium-induced neuromuscular block (control)
Number of subjects: 36
Study 7338895 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling biofeedback training
Number of subjects: 24
Study 7338895 — intervention group
Group type: EXPERIMENTAL
Intervention: Warming biofeedback training
Number of subjects: 24
Study 7338895 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger site biofeedback training
Number of subjects: 24
Study 7338895 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporal artery site biofeedback training
Number of subjects: 24
Study 31185067 — intervention group
Group type: EXPERIMENTAL
Intervention: Network Scale Up (NSU) methodology using proportional method
Number of subjects: 2500
Study 31185067 — intervention group
Group type: EXPERIMENTAL
Intervention: Network Scale Up (NSU) methodology using data-based method
Number of subjects: 2500
Study 31185067 — intervention group
Group type: COMPARATOR
Intervention: Direct estimate considered as gold standard
Number of subjects: 2500
Study 31185067 — intervention group
Group type: EXPERIMENTAL
Intervention: Data-based method for calculating network size (C)
Number of subjects: 2500
Study 27702624 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 mg intravitreal aflibercept injections (IAIs)
Number of subjects: 60
Study 27702624 — intervention group
Group type: COMPARATOR
Intervention: Macular laser
Number of subjects: 60
Study 25956368 — intervention group
Group type: COMPARATOR
Intervention: ET ≥3
Number of subjects: 6073
Study 25956368 — intervention group
Group type: COMPARATOR
Intervention: FHB >1
Number of subjects: 6073
Study 25956368 — intervention group
Group type: COMPARATOR
Intervention: Nulliparity
Number of subjects: 6073
Study 24052800 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive stimulation treatment
Number of subjects: 30
Study 24052800 — intervention group
Group type: COMPARATOR
Intervention: Occupational therapy (placebo)
Number of subjects: 30
Study 24052800 — intervention group
Group type: COMPARATOR
Intervention: Usual activities of the nursing home (control)
Number of subjects: 30
Study 21407218 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine plus vinorelbine (GemVin)
Number of subjects: 141
Study 21407218 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine plus cisplatin (GemCis)
Number of subjects: 141
Study 21407218 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine plus capecitabine (GemCap)
Number of subjects: 141
Study 19390280 — intervention group
Group type: EXPERIMENTAL
Intervention: Hernia sac laparoscopy (group A, 21 patients)
Number of subjects: 41
Study 19390280 — intervention group
Group type: COMPARATOR
Intervention: Standard management without laparoscopy (group B, 20 patients)
Number of subjects: 41
Study 17380985 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental textbook
Number of subjects: 0
Study 17380985 — intervention group
Group type: COMPARATOR
Intervention: Control textbook (not explicitly named)
Number of subjects: 0
Study 15039148 — intervention group
Group type: COMPARATOR
Intervention: Amino acid infusion (10% Travasol)
Number of subjects: 16
Study 15039148 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (2 mg orally every 6 h for 3 days)
Number of subjects: 16
Study 15039148 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid infusion (10% Travasol) with dexamethasone
Number of subjects: 16
Study 11511425 — intervention group
Group type: EXPERIMENTAL
Intervention: NPR‐C receptor density in patients with HF (class III‐IV)
Number of subjects: 18
Study 11511425 — intervention group
Group type: EXPERIMENTAL
Intervention: NPR‐C receptor density in patients with HF (class I‐II)
Number of subjects: 18
Study 11511425 — intervention group
Group type: COMPARATOR
Intervention: NPR‐C receptor density in healthy controls
Number of subjects: 18
Study 11511425 — intervention group
Group type: COMPARATOR
Intervention: Comparison of NPR‐C receptor density between class III‐IV HF patients and controls
Number of subjects: 18
Study 11511425 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of NPR‐C receptor density between class III‐IV HF patients and class I‐II HF patients
Number of subjects: 18
Study 9477538 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-session relationship violence prevention program
Number of subjects: 0
Study 9477538 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 7887101 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% mepivacaine‐1 (Meaverin)
Number of subjects: 600
Study 7887101 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% procaine (Novocain)
Number of subjects: 600
Study 7887101 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 600
Study 7887101 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% prilocaine (Xylonest)
Number of subjects: 600
Study 7887101 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lidocaine (Xylocain)
Number of subjects: 600
Study 7887101 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% mepivacaine‐2 (Scandicain)
Number of subjects: 600
Study 3171102 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical peripheral iridectomy
Number of subjects: 60
Study 3171102 — intervention group
Group type: COMPARATOR
Intervention: Argon laser iridotomy
Number of subjects: 60
Study 29135656 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-monthly creatinine clearance (CrCl) monitoring
Number of subjects: 5358
Study 29135656 — intervention group
Group type: COMPARATOR
Intervention: 6-monthly creatinine clearance (CrCl) monitoring
Number of subjects: 5358
Study 27154160 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial artery (RA) grafts
Number of subjects: 234
Study 27154160 — intervention group
Group type: COMPARATOR
Intervention: Saphenous vein grafts (SVGs)
Number of subjects: 234
Study 27154160 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with significant graft stenosis
Number of subjects: 234
Study 27154160 — intervention group
Group type: COMPARATOR
Intervention: Patients without significant graft stenosis
Number of subjects: 234
Study 24251386 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial removable dental prostheses (RDP)
Number of subjects: 92
Study 24251386 — intervention group
Group type: EXPERIMENTAL
Intervention: Functionally orientated treatment based on the shortened dental arch concept (SDA)
Number of subjects: 92
Study 24251386 — intervention group
Group type: COMPARATOR
Intervention: SDA
Number of subjects: 92
Study 22377834 — intervention group
Group type: EXPERIMENTAL
Intervention: Text based intervention
Number of subjects: 863
Study 22377834 — intervention group
Group type: EXPERIMENTAL
Intervention: Video based intervention
Number of subjects: 863
Study 22377834 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention
Number of subjects: 863
Study 22377834 — intervention group
Group type: COMPARATOR
Intervention: Mismatched group (participants who preferred a different mode)
Number of subjects: 863
Study 22377834 — intervention group
Group type: EXPERIMENTAL
Intervention: Matched group (participants who preferred their assigned mode)
Number of subjects: 863
Study 22377834 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (matched and mismatched)
Number of subjects: 863
Study 22377834 — intervention group
Group type: COMPARATOR
Intervention: Mismatched group
Number of subjects: 863
Study 22377834 — intervention group
Group type: EXPERIMENTAL
Intervention: Matched group
Number of subjects: 863
Study 20869107 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-layer urethrovesical (UV) anastomosis
Number of subjects: 116
Study 20869107 — intervention group
Group type: COMPARATOR
Intervention: Single-layer urethrovesical (UV) anastomosis
Number of subjects: 116
Study 18711405 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG with intramuscular or intracoronary administration of BMCs
Number of subjects: 63
Study 18711405 — intervention group
Group type: COMPARATOR
Intervention: CABG alone
Number of subjects: 63
Study 15866056 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin lispro
Number of subjects: 40
Study 15866056 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular insulin
Number of subjects: 40
Study 15866056 — intervention group
Group type: COMPARATOR
Intervention: Nondiabetic control (no insulin)
Number of subjects: 40
Study 12067326 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrophysiological examination
Number of subjects: 31
Study 12067326 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperexcitability index (HI)
Number of subjects: 31
Study 12067326 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acids acting as neurotransmitters
Number of subjects: 31
Study 9708578 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary rounds
Number of subjects: 1102
Study 9708578 — intervention group
Group type: COMPARATOR
Intervention: Traditional rounds
Number of subjects: 1102
Study 8544207 — intervention group
Group type: EXPERIMENTAL
Intervention: Hubcrank propulsion mechanism
Number of subjects: 10
Study 8544207 — intervention group
Group type: COMPARATOR
Intervention: Handrim propulsion mechanism
Number of subjects: 10
Study 2223423 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA and prednisolone
Number of subjects: 66
Study 2223423 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA and azathioprine and prednisolone
Number of subjects: 66
Study 2223423 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA concentrations
Number of subjects: 66
Study 2223423 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA concentrations measured by polyclonal r.i.a.
Number of subjects: 66
Study 2223423 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA concentrations measured by specific monoclonal r.i.a.
Number of subjects: 66
Study 2223423 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA concentrations measured by h.p.l.c.
Number of subjects: 66
Study 396214 — intervention group
Group type: EXPERIMENTAL
Intervention: suxibuzon
Number of subjects: 30
Study 396214 — intervention group
Group type: COMPARATOR
Intervention: indomethacin
Number of subjects: 30
Study 31957070 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g amoxicillin pre-operative and 500 mg thrice daily on days 1-3 post-operative
Number of subjects: 236
Study 31957070 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 236
Study 30824647 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg BID
Number of subjects: 317
Study 30824647 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg BID
Number of subjects: 317
Study 30824647 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg once every 2 weeks
Number of subjects: 317
Study 30824647 — intervention group
Group type: COMPARATOR
Intervention: Tofacitinib and Adalimumab
Number of subjects: 317
Study 30824647 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline CRP levels > 2.87 mg/l
Number of subjects: 317
Study 28067745 — intervention group
Group type: EXPERIMENTAL
Intervention: Trospium chloride XR 60 mg daily
Number of subjects: 59
Study 28067745 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 26124478 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 921
Study 26124478 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 921
Study 23042474 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 216
Study 23042474 — intervention group
Group type: COMPARATOR
Intervention: Education Control (EC)
Number of subjects: 216
Study 22185811 — intervention group
Group type: EXPERIMENTAL
Intervention: mpHBV (10 µg HBsAg)
Number of subjects: 538
Study 22185811 — intervention group
Group type: EXPERIMENTAL
Intervention: RECOMBIVAX HB™ (10 µg HBsAg)
Number of subjects: 538
Study 22185811 — intervention group
Group type: EXPERIMENTAL
Intervention: ENGERIX‐B™ (20 µg HBsAg)
Number of subjects: 538
Study 18940221 — intervention group
Group type: EXPERIMENTAL
Intervention: Encepur Children
Number of subjects: 334
Study 18940221 — intervention group
Group type: COMPARATOR
Intervention: FSME‐IMMUN Junior
Number of subjects: 334
Study 18940221 — intervention group
Group type: EXPERIMENTAL
Intervention: Encepur Children (third dose)
Number of subjects: 334
Study 18940221 — intervention group
Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 334
Study 17075252 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.025% levocabastine hydrochloride ophthalmic suspension
Number of subjects: 24
Study 17075252 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 24
Study 15452470 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult TEE probe
Number of subjects: 20
Study 15452470 — intervention group
Group type: COMPARATOR
Intervention: Pediatric TEE probe
Number of subjects: 20
Study 11525550 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician assessment of habitual contact lens fluorescein patterns
Number of subjects: 0
Study 11525550 — intervention group
Group type: EXPERIMENTAL
Intervention: Photograph readers' assessment of habitual contact lens fluorescein patterns
Number of subjects: 0
Study 11525550 — intervention group
Group type: EXPERIMENTAL
Intervention: Photograph readers' re-reads of fluorescein pattern slides
Number of subjects: 0
Study 11525550 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician assessment of habitual fit fluorescein patterns
Number of subjects: 0
Study 10188418 — intervention group
Group type: EXPERIMENTAL
Intervention: Snoezelen sensory environment intervention
Number of subjects: 0
Study 10188418 — intervention group
Group type: COMPARATOR
Intervention: Pain management programme (multidisciplinary approach)
Number of subjects: 0
Study 7918818 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone survey (response rate 49%)
Number of subjects: 0
Study 7918818 — intervention group
Group type: COMPARATOR
Intervention: Household survey (response rate 77%)
Number of subjects: 0
Study 2454372 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (12.5 to 200 mg)
Number of subjects: 6
Study 2454372 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (40 to 320 mg)
Number of subjects: 6
Study 2454372 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol (2.5 to 20 mg)
Number of subjects: 6
Study 2454372 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol (50 to 400 mg)
Number of subjects: 6
Study 2454372 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 31924530 — intervention group
Group type: EXPERIMENTAL
Intervention: Scleral rigid gas permeable contact lenses (SL)
Number of subjects: 34
Study 31924530 — intervention group
Group type: COMPARATOR
Intervention: Corneal rigid gas permeable contact lenses (CoL)
Number of subjects: 34
Study 29423840 — intervention group
Group type: EXPERIMENTAL
Intervention: LED therapy (λ627 ± 10 nm) with an energy density of 10 J/cm2 for 6 days
Number of subjects: 40
Study 29423840 — intervention group
Group type: COMPARATOR
Intervention: Placebo therapy (LED therapy turned off) for 6 days
Number of subjects: 40
Study 26727411 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive debiasing intervention (education on cognitive pitfalls and corrective strategies)
Number of subjects: 137
Study 26727411 — intervention group
Group type: COMPARATOR
Intervention: Brief overview of PBD (control condition)
Number of subjects: 137
Study 24865166 — intervention group
Group type: EXPERIMENTAL
Intervention: Active for Life Year 5 (AFLY5) intervention
Number of subjects: 2221
Study 24865166 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard teaching)
Number of subjects: 2221
Study 23225211 — intervention group
Group type: EXPERIMENTAL
Intervention: Lycopene-enriched virgin olive oil (7 mg lycopene day(‐1))
Number of subjects: 3
Study 23225211 — intervention group
Group type: COMPARATOR
Intervention: Virgin olive oil
Number of subjects: 3
Study 23225211 — intervention group
Group type: COMPARATOR
Intervention: Sunflower oil
Number of subjects: 3
Study 21519311 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter insertion 0 to 1 cm past the needle tip
Number of subjects: 100
Study 21519311 — intervention group
Group type: COMPARATOR
Intervention: Catheter insertion 5 to 6 cm past the needle tip
Number of subjects: 100
Study 18274695 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (0.1 mg/d)
Number of subjects: 56
Study 18274695 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 16509174 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management education programme 'Airways'
Number of subjects: 0
Study 16509174 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 15080229 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Electrical Therapy (FET)
Number of subjects: 28
Study 15080229 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 28
Study 10759052 — intervention group
Group type: EXPERIMENTAL
Intervention: Operational Stress Training Package
Number of subjects: 106
Study 10759052 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological Debriefing (PD)
Number of subjects: 106
Study 10759052 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PD)
Number of subjects: 106
Study 8847329 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid ingestion (FR)
Number of subjects: 5
Study 1403589 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiseptic mouthwash
Number of subjects: 18
Study 1403589 — intervention group
Group type: COMPARATOR
Intervention: Control rinse
Number of subjects: 18
Study 3602014 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline ('Trental' 400) 400 mg 3-times daily for two 3-month periods interrupted by a 4-week wash-out period
Number of subjects: 60
Study 3602014 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 29032853 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidants and zinc supplementation
Number of subjects: 879
Study 29032853 — intervention group
Group type: COMPARATOR
Intervention: Genotype claims
Number of subjects: 879
Study 26450456 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec (IDeg)
Number of subjects: 40
Study 26450456 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine (IGlar)
Number of subjects: 40
Study 24851237 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNTA (10 U)
Number of subjects: 12
Study 24851237 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 12
Study 22944392 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate passive motion
Number of subjects: 100
Study 22944392 — intervention group
Group type: COMPARATOR
Intervention: Strict immobilization
Number of subjects: 100
Study 20691129 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO-enriched meal
Number of subjects: 20
Study 20691129 — intervention group
Group type: COMPARATOR
Intervention: Monounsaturated fat-enriched meal
Number of subjects: 20
Study 20691129 — intervention group
Group type: COMPARATOR
Intervention: Saturated fat-enriched meal
Number of subjects: 20
Study 18313028 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamate injection into the masseter muscle
Number of subjects: 57
Study 19422443 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter-directed thrombolysis (CDT)
Number of subjects: 103
Study 19422443 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone (Control)
Number of subjects: 103
Study 15002073 — intervention group
Group type: EXPERIMENTAL
Intervention: Normothermia (37 degrees C)
Number of subjects: 48
Study 15002073 — intervention group
Group type: COMPARATOR
Intervention: Hypothermia (32 degrees C)
Number of subjects: 48
Study 11725598 — intervention group
Group type: EXPERIMENTAL
Intervention: Shuttle walking test with fitness training
Number of subjects: 44
Study 11725598 — intervention group
Group type: EXPERIMENTAL
Intervention: Shuttle walking test with various orthopaedic treatments
Number of subjects: 44
Study 11725598 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 44
Study 11725598 — intervention group
Group type: EXPERIMENTAL
Intervention: Shuttle walking test reliability
Number of subjects: 44
Study 9012640 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (20 mg/d)
Number of subjects: 5
Study 9012640 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 9012640 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (normolipidemic)
Number of subjects: 5